GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation

Author： Mazzon E. Serraino I. Li J.-H. Dugo L. Caputi A.P. Zhang J. Cuzzocrea S.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.415, Iss.1, 2001-03, pp. : 85-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation

By Cuzzocrea S. Zingarelli B. Gilad E. Hake P. Salzman A.L. Szabo C.

European Journal of Pharmacology, Vol. 342, Iss. 1, 1998-01 ,pp. : 67-76

Elsevier

Access to resources Recommend Favorite

Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis

By Zingarelli B. O'Connor M. Hake P.W.

European Journal of Pharmacology, Vol. 469, Iss. 1, 2003-05 ,pp. : 183-194

Elsevier

Access to resources Recommend Favorite

Role of the Peroxynitrite - Poly (ADP-Ribose) Polymerase Pathway in the Pathogenesis of Liver Injury

Current Pharmaceutical Design, Vol. 12, Iss. 23, 2006-08 ,pp. : 2903-2910

Bentham Science Publishers

Access to resources Recommend Favorite

Poly (ADP-ribose) polymerase, nitric oxide and cell death

By Pieper A.A. Verma A. Zhang J. Snyder S.H.

Trends in Pharmacological Sciences, Vol. 20, Iss. 4, 1999-04 ,pp. : 171-181

Elsevier

Access to resources Recommend Favorite

Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 4, 2011-12 ,pp. : 326-333

Bentham Science Publishers

Access to resources Recommend Favorite